First Financial Bankshares Inc Sells 1,596 Shares of CVS Health Co. (NYSE:CVS)

First Financial Bankshares Inc lessened its holdings in CVS Health Co. (NYSE:CVS) by 19.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,693 shares of the pharmacy operator’s stock after selling 1,596 shares during the quarter. First Financial Bankshares Inc’s holdings in CVS Health were worth $300,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Vinva Investment Management Ltd lifted its holdings in CVS Health by 4.2% during the 4th quarter. Vinva Investment Management Ltd now owns 58,789 shares of the pharmacy operator’s stock valued at $2,583,000 after buying an additional 2,343 shares in the last quarter. Platinum Investment Management Ltd. bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $89,000. North Forty Two & Co. purchased a new stake in shares of CVS Health in the fourth quarter valued at approximately $354,000. OVERSEA CHINESE BANKING Corp Ltd increased its holdings in CVS Health by 92.1% during the 4th quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 34,125 shares of the pharmacy operator’s stock worth $1,518,000 after purchasing an additional 16,365 shares during the period. Finally, Xponance Inc. raised its position in CVS Health by 2.5% during the 4th quarter. Xponance Inc. now owns 188,834 shares of the pharmacy operator’s stock valued at $8,477,000 after purchasing an additional 4,585 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 1.3 %

NYSE:CVS opened at $67.49 on Wednesday. The company has a market capitalization of $85.09 billion, a P/E ratio of 18.44, a PEG ratio of 0.98 and a beta of 0.54. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The firm has a fifty day simple moving average of $59.32 and a 200-day simple moving average of $57.12.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.94%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 72.68%.

Analyst Ratings Changes

CVS has been the topic of several research reports. Argus set a $77.00 price target on CVS Health in a research note on Tuesday, February 18th. JPMorgan Chase & Co. raised their target price on shares of CVS Health from $80.00 to $81.00 and gave the company an “overweight” rating in a research report on Tuesday, February 18th. Piper Sandler dropped their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. TD Cowen boosted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Finally, Wolfe Research increased their target price on CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $69.83.

Insider Activity

In other news, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael F. Mahoney purchased 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.